Skip to main content
Caplight Logo









Alixia

Alixia

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://alixia.com

Last Round

Early Funding

Sep 1, 2025

Total Funding Raised

$2.33M

Company Overview

Alixia operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Early Funding round in September 2025.

Alixia is a biotechnology company that develops therapeutics to combat cancer drug resistance by targeting the tumor ecosystem.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Alixia Comparables

Compare Alixia with similar companies based on industry and business-model similarity.

Alixia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ResistanceBio
84%
Novasenta
83%
Incendia Therapeutics
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Alixia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 1, 2025
Series AJul 23, 2024
AcceleratorMar 29, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Alixia Investors

Notable investors and investment history

Alixia investors
InvestorRounds
ZAKA VCEarly Funding
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 379% MoM, from 135 to 646.

Book a demo to see all signals

For institutional investors. Book with your work email.

Alixia Filings

Explore SEC and related filing metadata, where available.

Alixia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Alixia's valuation, stock price, and market status.

Is Alixia a public or private company?

Alixia is a private company.

What is the current stock price of Alixia?

Alixia is a private company, so its shares have no public market price. Caplight tracks Alixia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Alixia worth (valuation)?

Valuation information for Alixia is not publicly available.

Can I buy Alixia stock?

Alixia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Alixia's last funding round?

Alixia's most recent funding round was Early Funding on September 1, 2025.

Who are the main investors in Alixia?

Key investors in Alixia include ZAKA VC, Y Combinator.

Will Alixia IPO soon?

No public IPO plans have been announced for Alixia.

How can I track Alixia secondary market activity?

Caplight tracks bids, offers, and trades in Alixia's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2022
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?